Skip to main content
. 2006 Jul;62(1):97–112. doi: 10.1111/j.1365-2125.2006.02719.x

Figure 1.

Figure 1

Plasma imatinib concentrations observed in patients receiving imatinib, together with the mean population prediction (solid line) and 90% prediction interval (dashed lines). The graphs represent a once (upper part) or twice (lower part) daily regimen, based either on the demographic covariates model (left) or on the final α1-acid glycoprotein (AGP) model (right) (values adjusted to 400 mg q.d.; AGP model curves generated assuming mean values of AGP level and fu)